Health TrialsbyHealthPanel

Ultrasound Guided Rhomboid Intercostal Plane Block Versus Thoracic Erector Spinae Plane Block in Upper Abdominal Surgery

ConditionsUltrasoundRhomboid Intercostal Plane BlockThoracic Erector Spinae Plane BlockUpper Abdominal Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-65
SponsorTanta University

About this trial

The aim of the work is to evaluate the analgesic efficacy of ultrasound guided rhomboid intercostal plane block versus ultrasound guided thoracic erector spinae block in patients undergoing upper abdominal surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 21-65 years.

Both gender.

American Society of Anesthesiologists (ASA) classification I-II.

Presented for elective upper abdominal surgery.

Disqualifiers

Patients refused to participate.

Patients with known or suspected allergy to the used medication.

Patients with preoperative chronic pain.

Patients with major cardiac, renal, respiratory, or hepatic disease.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Rhomboid intercostal plane block

    Drug

    The patients in this group will receive ultrasound -guided rhomboid intercostal plane block after induction of general anesthesia. The rhomboid intercostal block will be performed at the T6 levels, bilaterally.

  • Erector spinae plane block

    Other intervention

    The patients in this group will receive ultrasound -guided Erector spinae plane block after induction of general anesthesia. Erector spinae plane block will be performed at the level of T9 bilaterally.

  • Control group

    Other intervention

    No block will be performed, and patient will receive general anesthesia (GA) only.

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Rhomboid intercostal plane block groupExperimental treatment 1 intervention
Group B: Erector spinae plane block groupExperimental treatment 1 intervention
Group C: Control groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total morphine consumption

Rescue analgesia will be provided in the form of IV morphine 3 mg boluses if the patient indicates The visual analogue scale (VAS). ≥ 4 with maximum dose 20 mg for 24 hours. The total amount of morphine (mg) given will be recorded for the 3 groups.

Time frame
24 hours postoperatively

Secondary outcomes

1

Degree of pain

Postoperative pain will be assessed by visual analogue scale (VAS) 30 min from admission to PACU, 2, 4, 6, 12, 18 and 24 h postoperative (0= no pain, 10= sever pain).

Time frame
24 hours postoperatively
2

Time to 1st request of rescue analgesia

Time to 1st request for the rescue of analgesia (time from the end of surgery till first dose of morphine administrated ) will be recorded.

Time frame
24 hours postoperatively
3

Heart rate

Heart rate will be measured preoperative, after induction, after receiving block and every 15 min till the end of surgery

Time frame
Every 15 min till the end of surgery
4

Mean arterial blood pressure

Mean arterial blood pressure will be measured preoperative, after induction, after receiving block and every 15 min till the end of surgery

Time frame
Every 15 min till the end of surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov
Apply now